Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignant Tumour”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00038441
What this trial is testing

Phase I Trial of Intramural Injection of DTI-015 for Recurrent Malignant Gliomas

Who this might be right for
GliomaBrain Neoplasms
M.D. Anderson Cancer Center 39
Not applicableNot Yet RecruitingNCT07664241
What this trial is testing

Peer Support Program for Improving Quality of Life Among Head and Neck Patients, Connecting Through Cancer Trial

Who this might be right for
Malignant Head and Neck Neoplasm
OHSU Knight Cancer Institute 56
Large-scale testing (Phase 3)Ended earlyNCT00089141
What this trial is testing

Mycophenolate Mofetil (MMF) for Treatment of Chronic Graft-versus-host Disease (GVHD)

Who this might be right for
Cancer
Martin, Paul 151
Early research (Phase 1)Study completedNCT00025454
What this trial is testing

R115777 in Treating Patients With Advanced Solid Tumors

Who this might be right for
Unspecified Adult Solid Tumor, Protocol Specific
City of Hope Medical Center
Not applicableStudy completedNCT00899782
What this trial is testing

Collection and Storage of Blood and Tissue Samples From Patients Who Are Undergoing Surgery For Lung Cancer

Who this might be right for
Lung CarcinomaLung NeoplasmMalignant Lung Neoplasm
Alliance for Clinical Trials in Oncology 500
Testing effectiveness (Phase 2)Study completedNCT00256282
What this trial is testing

Docetaxel and Vinorelbine Plus Sargramostim in Metastatic Malignant Melanoma

Who this might be right for
Metastatic Melanoma
John P. Fruehauf 52
Testing effectiveness (Phase 2)Study completedNCT00002673
What this trial is testing

Immunotherapy in Treating Patients Who Are Undergoing Bone Marrow or Peripheral Stem Cell Transplantation

Who this might be right for
Cancer
Fred Hutchinson Cancer Center 30
Early research (Phase 1)UnknownNCT05554666
What this trial is testing

ASKG315 in Patients With Advanced Solid Tumors.

Who this might be right for
Advanced Solid Tumors
AskGene Pharma, Inc. 56
Not applicableStudy completedNCT06729931
What this trial is testing

Quantitative C-Reactive Protein for Differentiating Tuberculous and Malignant Pleural Effusion: a Cross-Sectional Study

Who this might be right for
Pleural EffusionMalignant Pleural EffusionsTuberculous Pleural Effusion
Maharajgunj Medical Campus 81
Not applicableStudy completedNCT05100173
What this trial is testing

Clinical Evaluation of Genetron IDH1 PCR Kit in Glioma Patients

Who this might be right for
Glioma, MalignantGlioma, Mixed
Genetron Health 1,192
Testing effectiveness (Phase 2)Study completedNCT02083354
What this trial is testing

Study to Investigate the Objective Response Rate of Dabrafenib in Combination With Trametinib in Subjects With BRAF V600 Mutation-Positive Melanoma

Who this might be right for
CancerMelanoma
Novartis Pharmaceuticals 77
Not applicableStudy completedNCT06073951
What this trial is testing

Evaluation of a Couple-Based Physical Activity Intervention

Who this might be right for
Hematopoietic and Lymphoid System NeoplasmMalignant Solid Neoplasm
Mayo Clinic 96
Not applicableUnknownNCT02439931
What this trial is testing

Remote Psychosocial Intervention for Brain Tumour Survivors

Who this might be right for
Quality of Life
British Columbia Cancer Agency 10
Early research (Phase 1)Study completedNCT01531361
What this trial is testing

Vemurafenib With Sorafenib Tosylate or Crizotinib in Treating Patients With Advanced Malignancies With BRAF Mutations

Who this might be right for
Advanced Malignant NeoplasmBRAF Gene MutationMetastatic Malignant Neoplasm+2 more
M.D. Anderson Cancer Center 46
Testing effectiveness (Phase 2)Ended earlyNCT02154529
What this trial is testing

Study of the Combination of KD019 and Trastuzumab in Subjects With HER2-Positive Metastatic Breast Cancer

Who this might be right for
HER-2 Positive Breast CancerMetastatic Malignant Neoplasm to Brain
Kadmon Corporation, LLC 17
Testing effectiveness (Phase 2)Study completedNCT05795595
What this trial is testing

A Safety and Efficacy Study Evaluating CTX131 in Adult Subjects With Relapsed or Refractory Solid Tumors

Who this might be right for
Clear Cell Renal Cell CarcinomaCervical CarcinomaEsophageal Carcinoma+2 more
CRISPR Therapeutics AG 19
Very early researchActive Not RecruitingNCT05045027
What this trial is testing

Simultaneous Multinuclear Metabolic MRI in Newly Diagnosed or Recurrent Glioma

Who this might be right for
GliomaMalignant GliomaRecurrent Glioma+1 more
Jonsson Comprehensive Cancer Center 36
Large-scale testing (Phase 3)Study completedNCT01309386
What this trial is testing

A Safety and Efficacy Study of Oral Tapentadol Extended-Release in Japanese Participants

Who this might be right for
Neoplasms
Janssen Pharmaceutical K.K. 100
Not applicableUnknownNCT05602337
What this trial is testing

A Prospective Multicenter Sample Collection Study Using Non-invasive Methods to Investigate Mutation Burden in Non-lesional Facial Skin of Patients With a Hx of Skin Cancer

Who this might be right for
Melanoma and Other Malignant Neoplasms of Skin
DermTech 180
Testing effectiveness (Phase 2)Active Not RecruitingNCT05924672
What this trial is testing

Efficacy of Ra-223 in PSMA PET Optimally Selected Patients

Who this might be right for
Castration-Resistant Prostate CarcinomaMetastatic Malignant Neoplasm in the BoneStage IVB Prostate Cancer AJCC v8
University of California, San Francisco 2
Next Page